|
Chief IP Counsel Mentions AIPLA Economic Survey In An InterviewDear Law Practice Management Committee Members:
Please follow the link below to read an interview with Philip S.
Johnson, Chief Intellectual Property Counsel at Johnson & Johnson,
which was published in Landslide, a magazine published by the ABA
Section of Intellectual Property
Law. Mr. Johnson specifically refers to the AIPLA Economic Survey.
http://www.americanbar.org/publications/landslide/2012_13/march_april/diversity_from_the_corporate_perspective.html
Thanks,
Donika Pentcheva Women in IP Law Networking Event on May 23rdWomen in Intellectual Property Law Networking Event
May 23, 2013
The AIPLA Women in IP Networking Events are held on a single night in various cities across the country in order to empower and celebrate women in the profession on a localized and national level. This event is in its sixth year; past years have seen attendance upwards of 1000 individuals across the United States and have included international locations in Canada as well as Hong Kong. The purpose of the event is to provide an informal forum for women in IP law to come together on a single night to celebrate women in the profession and to provide an opportunity for localized networking, mentoring, and education. This year’s event will be held on May 23, 2013, please note this is a date change from May 16, 2013.
Each location will be joined by teleconference and welcomed by the Chair of the AIPLA Women in IP Law Committee, the Vice-Chair of the AIPLA Women in IP Law Committee, and the President of AIPLA. A highlight of the teleconference is the opening roll call where each city is called out by name and then the host and attendees in that city have an opportunity to state which firm their dinner is being held at and the number of women in attendance.
Please see the list below for event locations. If you do not see your location listed on this year’s list and would like to host an event next year, please contact eselinger@dfw.conleyrose.com
“For a list of host cities and firms please click HERE.”
Chair: Carine M. Doyle cdoyle@lewisrice.com
MeetingAIPLA 2013 SPRING MEETING IN SEATTLEONLINE PROGRAMS COMMITTEE MEETING
Wednesday, MAY 1, 2013 | 4:30 – 5:30 PMMeeting Room: BLAKELY, SAN JUAN LEVEL
As part of the AIPLA 2013 Spring Meeting in Seattle, the Online Programs Committee will meet on Wednesday, May 1, at 4:30 – 5:30 PM (Pacific time). We invite those attending the Spring Meeting to join us in person (Blakely Room, San Juan Level) and everyone else to join via teleconference (see call-in details below). The agenda for our meeting is attached. Given that our online program coordinators are the heart of the committee, we would like to have as many of you as possible participate in the meeting.
Dial: 1-866-906- 9372
International: 857-472-7342
Participant Code: 2083807
GAC advice on gTLDs non binding - ICANNSee World IP Review article at: http://www.worldipreview.com/news/gac-advice-on-gtlds-not-binding-icann?utm_source=World+IP+Review&utm_campaign=9ea485855d-WIPR_Digital_Newsletter_18_04_2013&utm_medium=email AIPLA’s IP Practice in Latin America and Biotechnology Committees - Spring Meeting – Seattle May 1-3, 2013 – Joint Committee Educational SessionDear Committee Members:
The IP Practice in Latin America and the Biotechnology and Committees will conduct a joint-committee educational session at the AIPLA’s Spring Meeting to be held in Seattle, WA in May of 2013. The topics will touch on some of the latest and most important issues affecting patent practitioners who file and prosecute patent applications and who procure and maintain patent protection on biotechnology related inventions in Latin America. The joint committee educational session will include four distinguished speakers, one each from Argentina, Brazil, Costa Rica and Mexico.
All four Latin American speakers come from the most prestigious and well known IP firms in their respective countries. All of our speakers are either senior associates, partners and/or managing partners of their respective firms and who represent pharmaceutical and biotechnology companies of all sizes, from around the world in the procurement of patents.
The four Latin American speakers include: (1) Mr. Ignacio Mr. Manuel Sanchez Echagüe from the MARVAL, O'FARRELL & MAIRAL firm located in Buenos Aires, Argentina; (2) Ms. Leonor Galvão de Botton, Ph.D. from the MURTA GOYANES firm located in Rio de Janeiro, Brazil; (3) Mr. Luis Diego Castro from the CASTRO & PAL ASOCIADOS firm located in San José, Costa Rica; and (4) Mr. Eugenio Pérez from the UHTHOFF, GÓMEZ VEGA & UHTHOFF firm located in Mexico City, Mexico.
The educational session will be moderated by Lynn C. Tyler, M.S., a partner and registered patent attorney at the BARNES & THORNBURG firm in their Indianapolis office from where he also Chairs the firm’s Food, Drug and Device Law Practice Group.
The topics to be addressed will cover (1) status of plant variety patent protection; (2) biological pharmaceuticals and biosimilars; (3) whether protection is available for diagnostics and gene patenting; and (4) any specific particularities in each country in obtaining and maintaining patent protection (i.e., compulsory licensing issues). The program will be a 2-hour educational session and therefore CLE credit will be available for those practitioners seeking such credit.
Each speaker will be making a 20-25 minute presentation augmented by Power Point slide presentations. The remaining time of the 2-hour session will be used for Q&A, comments and discussion directed by Mr. Tyler.
As of now, the session is scheduled for Thursday, May 2nd from 3:30pm-5:30pm in the Fifth Avenue Room, Grand Level. However, location and time are always subject to change and everyone is encouraged to confirm the meeting room, the time and the date when they arrive in Seattle.
Afterwards, as IP Practice in Latin America Committee tradition dictates, we will retire to a local establishment to have a refreshment and snack and to socialize among good friends and new colleagues in a more informal setting. Please join us. But kindly remember that this is neither an AIPLA nor an IPP-LatAm sponsored event and so each person is responsible for their own food and drink. Hope to see as many of you as possible in Seattle! Next Monthly Committee Teleconference: Tuesday, April 16, 2013Please note that because of a scheduling conflict with ICANN 46 7-11 April 2013 Beijing, the committee teleconference originally scheduled for April 9, 2013 (2 pm ET) will be held one week later instead on Tuesday, April 16, 2013 at the same time. Law Practice Management Committee Monthly Call / A Conversation for Completion / April 12, 2013, at 1pm Eastern (10am Pacific)Dear Law Practice Management Committee Members,
After a brief hiatus as we all worked through the new AIA provisions that went into effect in March, the AIPLA Law Practice Management Committee monthly call is back on schedule in April. Our Vice Chair, Rich Goldstein, will be presenting the last in our series of The Six Critical Conversations Every: “A Conversation for Completion.”
The call will be held on Friday, April 12, 2013, at 1PM EST / 10AM PST. The duration of the call will be 1 hour. The purpose of this and future monthly calls is to facilitate education, discussion, and support related to law practice management and leadership issues we all face.
If you have any leadership/management questions you would like addressed on the call, however, please email them to Rich (goldstein@goldsteinpc.com) or myself in advance. Time permitting, we are happy to discuss them.
Please note: To participate in the call, you must sign up in advance to obtain your own personal call-in phone number and pin. Please click here to sign up.
We look forward to having everyone on the call
Sincerely,
Dave Divine, Rich Goldstein and Donika Pentcheva Article discussing changing innovation models in Pharmaceutical Brand and Generics companiesIt highlights the issue of changing innovation models by Brand Pharma due to generic competition through addressing unmet needs, etc., and the adoption of innovation mechanisms in the generics industry to gain new products.
http://gabi-journal.net/the-generic-pharmaceutical-industry-moving-beyond-incremental-innovation-towards-re-innovation.html
Also, this might be a good chat topic between the Hatch Waxman and Biosimilars subcommittees.
|
|